Quick Answer
INTERPACE BIOSCIENCES, INC. reported Gross Profit of $24.13 million for fiscal year 2025.
INTERPACE BIOSCIENCES, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $24.13M | -19.4% |
| 2024 | $29.93M | +19.4% |
| 2023 | $25.06M | +37.4% |
| 2022 | $18.23M | -3.0% |
| 2021 | $18.80M | +75.3% |
| 2020 | $10.72M | +28.7% |
| 2019 | $8.33M | -28.8% |
| 2018 | $11.70M | +37.0% |
| 2017 | $8.54M | +32.5% |
| 2016 | $6.44M | +155.5% |
| 2015 | $2.52M | +1124.3% |
| 2014 | $206.0K | -99.1% |
| 2013 | $23.50M | -12.5% |
| 2012 | $26.86M | -17.3% |
| 2011 | $32.47M | +22.3% |
| 2010 | $26.55M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.44M | -31.2% | +3.1% |
| June 30, 2025 | $5.28M | -32.4% | -28.4% |
| March 31, 2025 | $7.37M | +16.8% | -6.7% |
| September 30, 2024 | $7.90M | +59.5% | +1.2% |
| June 30, 2024 | $7.81M | +14.2% | +23.7% |
| March 31, 2024 | $6.31M | +5.6% | +27.4% |
| September 30, 2023 | $4.95M | +4.7% | -27.5% |
| June 30, 2023 | $6.83M | +78.5% | +14.3% |
- INTERPACE BIOSCIENCES, INC. showed a decrease of -19.4% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, INTERPACE BIOSCIENCES, INC.’s gross profit has declined by 9.1% (from $26.55 million to $24.13 million).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: